OrganX is a NonProfit Health Organization (NPHO)
The NGO was established to eXponentially accelerate advances in Organ Technologies and patients access to Organ health
That's where a Non-Profit Health Organization differentiates itself from the private sector: Guided by patients
Our goal is threefold:
1) Partner with various Governments, IGOs, NGOs, Research institutions, Medical Associations and Private sector to enhance medical guidelines in order to foster faster HCP adoption and Patients use of new organ technologies.
2) Support world-class research institutions who lack proper funding to access frontier research capabilities with donations and/or loan of equipment, consumables and platforms to accelerate their research.
3) Work ourselves on bench technologies that many stakeholders are currently unable or unwilling to develop because too risky, too costly, too complex or too early in the R&D continuum through research partnerships, grants and donations.
OrganX chose to settle in Switzerland for its world's leading position in the combined fields of Nonprofit and Healthcare.
The country is at the heart of Europe and part of Schengen Free trade zone.
EU and Switzerland foster close relations in the fields of politics, trade and science. They have a long tradition of research partnership such Horizon 2020, Euratom, the Fusion Program and Healthcare initiatives. Switzerland also benefits from a 7 out of 180 countries ranking on the Transparency International ranking.
Most known Global Health Actors (GHA) such as Research and Academic institutions, Foundations, Associations, IGOs, NGOs, Governments, Private sectors are located there, creating a unique ecosystem.
World Health Organization
Médecins Sans Frontières
ETH & EPFL
World Economic Forum
Banff Foundation for Allograft Pathologv
Drugs for Neglected Diseases Initiative
Global Health Institute
Global Forum for Health Research
And more than 200+ others (...)
Our vision is to modernize medicine by enhancing medical guidelines and public health policies, support world's leading institutions to help them accelerate their research, and work on early technologies not currently ready for prime time.
Our goals goals directly align with WHO Digital Health's objectives. WHO believes that the use and scale up of digital health solutions can revolutionize how people worldwide achieve higher standards of health, and access services to promote and protect their health and well-being.
Digital health provides opportunities to accelerate progress in healthcare related Sustainable Development Goals (especially SDG 3) and achieving the triple billion targets -improve the health of 3 billions people by 2023- as articulated in United Nations WHO's Thirteenth General Program of Work
We provide financial and process support to world-leading research institutions by putting latest generation genomics, transcriptomics and digital equipment and consumable at disposal.
This allows the acceleration of advanced organ technologies development and therefore faster time to Patients
Our Public-Private-Partnership platform allows us to support countries in the developing world with under-invested healthcare ecosystems - particularly in Africa
We partner with Healthcare Authorities (HAs), HealthCare Organizations (HCOs) and Research Institutions (RIs) to set-up local or pan-countries biomedical research platforms and support research
A small proportion of research activities are performed out of developing counties and we ought to change this. Also, a lot of diseases prevalent in these countries are not well understood, diagnosed and treated, and would benefit from advanced digital technologies to further their understanding - especially the growing burden of NCDs
We established the first Blockchain Organs Exchange in the World supported by clinical institutions
At a time of global organs scarcity, this concept is going to revolutionize solid organs transplantation worldwide, combining Blockchain with AI
The exchange is operated on a nonprofit basis and aligns the incentives of all stakeholders along the transplantation continuum by making its processes more effective, efficient, transparent, secured and trustworthy - Creating a fully virtualized and tokenized transplant ecosystem with trust at its core
We leverage advanced AI combined with transcriptomics and gene expression capabilities to enhance current clinical practice
These minimally invasive diagnostics are improving disease monitoring, clinical decision, and patients’ outcome
This platform therefore increases the ability to detect organ injuries, multiple cancer types, autoimmune diseases or disease progression much earlier and more accurately than the standard of care through AI augmentation of recent biological and molecular testing technologies
Copyright © 2020 OrganX - All Rights Reserved
Powered by AI & Blockchain